Pages that link to "Q42150160"
Jump to navigation
Jump to search
The following pages link to IL-10 therapy in Crohn's disease: at the crossroads. Treatment of Crohn's disease with the anti-inflammatory cytokine interleukin 10. (Q42150160):
Displaying 28 items.
- Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease (Q26777400) (← links)
- CD19( ) B cells confer protection against experimental cerebral malaria in semi-immune rodent model (Q27318165) (← links)
- The relationship between the immune system and oral manifestations of inflammatory bowel disease: a review (Q28078219) (← links)
- IL-10/HMOX1 signaling modulates cochlear inflammation via negative regulation of MCP-1/CCL2 expression in cochlear fibrocytes. (Q30385810) (← links)
- Comparison of efficacy of the disease-specific LOX1- and constitutive cytomegalovirus-promoters in expressing interleukin 10 through adeno-associated virus 2/8 delivery in atherosclerotic mice (Q35148901) (← links)
- Therapeutic strategies in common variable immunodeficiency. (Q35162314) (← links)
- IL-10 and its related cytokines for treatment of inflammatory bowel disease (Q35678651) (← links)
- The role of mucosal T lymphocytes in regulating intestinal inflammation (Q36164906) (← links)
- Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants (Q36439020) (← links)
- Investigational therapies for celiac disease (Q37638684) (← links)
- Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity (Q37642857) (← links)
- Modulation of gut-associated lymphoid tissue functions with genetically modified Lactococcus lactis (Q37642861) (← links)
- Dendritic cells and multiple sclerosis: disease, tolerance and therapy (Q38070093) (← links)
- Why interleukin-10 supplementation does not work in Crohn's disease patients. (Q38120519) (← links)
- Design Advances in Particulate Systems for Biomedical Applications (Q38873026) (← links)
- Resolution of inflammation in inflammatory bowel disease (Q39367753) (← links)
- Adoptive transfer of helminth antigen-pulsed dendritic cells protects against the development of experimental colitis in mice. (Q41019894) (← links)
- Alterations to chromatin in intestinal macrophages link IL-10 deficiency to inappropriate inflammatory responses (Q41027903) (← links)
- CD47 fusion protein targets CD172a cells in Crohn's disease and dampens the production of IL-1β and TNF (Q42142744) (← links)
- Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases (Q43202907) (← links)
- Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423--a new phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity. (Q43260824) (← links)
- Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease (Q45876830) (← links)
- Production of interleukin-10 by combining a granulocyte and monocyte adsorption carrier with ulinastatin. (Q53140962) (← links)
- Heterogeneity of subordination of the IL-18/IFN-γ axis to caspase-1 among patients with Crohn's disease. (Q53429155) (← links)
- "Phage Transplantation in Allotransplantation": Possible Treatment in Graft-Versus-Host Disease? (Q54961695) (← links)
- Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease (Q64266062) (← links)
- Resolution of Crohn's disease (Q90268996) (← links)
- An immune therapy model for effective treatment on inflammatory bowel disease (Q99707492) (← links)